This trial will study the effectiveness of a new drug, lenacapavir, in preventing HIV infection in people who are at risk. The trial will have two parts: a cross-sectional study to estimate the background HIV infection rate, and a double-blind, randomized study to study the drug. This is a Phase 3 trial recruiting patients with History of syphilis, rectal gonorrhea, or rectal chlamydia in the last 24 weeks
00:00:11 How long is the study?
00:00:21 Who is eligible to participate?
00:00:53 Where is the trial located?
Explore withpower.com to learn more and see if you might be a fit for enrollment here: bit.ly/3VghIjg
#HIVInfection #HIVInfectionresearch #HIVInfectionclinicaltrials #HIVInfectionstudy #HIVInfectiontreatment #HIVInfectiontrials #OralLenacapavir #clinicaltrials
Негізгі бет New HIV Infection Clinical Trial: Oral Lenacapavir for Pre-Exposure Prophylaxis of HIV Infection
Пікірлер